These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17582275)

  • 41. Safety and effectiveness of permissive hypercapnia in the preterm infant.
    Miller JD; Carlo WA
    Curr Opin Pediatr; 2007 Apr; 19(2):142-4. PubMed ID: 17496755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchopulmonary dysplasia: clinical perspective.
    Jain D; Bancalari E
    Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):134-44. PubMed ID: 24578124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Recent findings on the subject of bronchopulmonary dysplasia].
    Livolsi P
    Pediatr Med Chir; 1988; 10(4):383-93. PubMed ID: 3068632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacotherapy in bronchopulmonary dysplasia.
    Blanchard PW; Brown TM; Coates AL
    Clin Perinatol; 1987 Dec; 14(4):881-910. PubMed ID: 3322629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive pharmacotherapy in neonates with respiratory failure.
    Fok TF
    Semin Fetal Neonatal Med; 2009 Feb; 14(1):49-55. PubMed ID: 18851933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New strategies for the prevention of bronchopulmonary dysplasia.
    Sinkin RA; Phelps DL
    Clin Perinatol; 1987 Sep; 14(3):599-620. PubMed ID: 3311541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell therapy: a novel treatment approach for bronchopulmonary dysplasia.
    Vosdoganes P; Lim R; Moss TJ; Wallace EM
    Pediatrics; 2012 Oct; 130(4):727-37. PubMed ID: 22945412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current therapy of bronchopulmonary dysplasia.
    Rush MG; Hazinski TA
    Clin Perinatol; 1992 Sep; 19(3):563-90. PubMed ID: 1526072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology.
    Jensen EA; Foglia EE; Schmidt B
    Clin Perinatol; 2015 Dec; 42(4):755-79. PubMed ID: 26593077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
    Bassler D
    J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia.
    Ma L; Zhou P; Neu J; Lin HC
    Paediatr Respir Rev; 2017 Mar; 22():83-88. PubMed ID: 27843119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal ventilatory strategies and surfactant to protect the preterm lungs.
    Ramanathan R
    Neonatology; 2008; 93(4):302-8. PubMed ID: 18525214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of bronchopulmonary dysplasia: current strategies.
    Jain D; Bancalari E
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):841-851. PubMed ID: 28774356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.
    Mandell EW; Kratimenos P; Abman SH; Steinhorn RH
    Clin Perinatol; 2019 Jun; 46(2):291-310. PubMed ID: 31010561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-inflammatory therapy in the neonatal intensive care unit: present and future.
    Watterberg K
    Semin Fetal Neonatal Med; 2006 Oct; 11(5):378-84. PubMed ID: 16632414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging drugs for the prevention of bronchopulmonary dysplasia.
    Greenough A
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):537-46. PubMed ID: 18764728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchopulmonary dysplasia--long term follow up.
    Greenough A
    Paediatr Respir Rev; 2006; 7 Suppl 1():S189-91. PubMed ID: 16798559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system.
    Short EJ; Kirchner HL; Asaad GR; Fulton SE; Lewis BA; Klein N; Eisengart S; Baley J; Kercsmar C; Min MO; Singer LT
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1082-7. PubMed ID: 17984411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
    Kaempf JW; Campbell B; Brown A; Bowers K; Gallegos R; Goldsmith JP
    J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.